Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers in Women With Obesity and Other Risk Factors for Breast Cancer

NCT06485089 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT06485089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06485089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers in Women With Obesity and Other Risk Factors for Breast Cancer
Lead sponsor
University of Kansas Medical Center
Phase
Observational
Overall status
Completed
Start date
September 14, 2024
Completion date
March 25, 2026
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer risk, obesity